Indefinite Delivery Contract SPE2DB24D9222

Award Date 2/7/24
Last Date to Order 12/31/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $499,999,999 single-award IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group supplies...
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract, which runs through December 31, 2025, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. Key product categories include branded and generic medications...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued up to $499,999,999, covers the period from October 2, 2024 through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military health facilities worldwide....
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Illinois. The $499,999,999 single-award IDC, contract #SPE2DB24D9212, has a period of performance through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will provide a broad range of pharmaceutical products and medical supplies to support the medical needs of U.S. military facilities globally. Key product...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $499,999,999 contract, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of branded and generic...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 single-award IDC, under the SPE2DB program, runs through December 31, 2025 and allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The IDC covers a vast array...
This indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The single-award IDC, valued up to $499,999,999, covers the period from October 10, 2024 through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 single-award IDC, with a period of performance through December 31, 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide....
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The single-award IDC, valued at up to $499,999,999, covers the provision of a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide under the SPE2DB program. The contract includes the delivery of a wide variety of...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at $499,999,999, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC covers an extensive portfolio of...
  • SPE2DB24D9222
    Indefinite Delivery Contract
  • 241
    Federal Contract Awards

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Illinois. The single-award contract, valued up to $499,999,999, runs through December 31, 2025 and is part of the DLA's SPE2DB program.

Under this IDC, DMS Pharmaceutical Group will provide a broad range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. Major categories of goods to be delivered include naltrexone tablets, botulinum toxin injections, contraceptive implants, chemotherapy drugs, HIV antiretrovirals, ophthalmic solutions, injectable anesthetics, and other branded and generic medications. The IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites.

Generated 5/8/24, 9:11 AM